Park Place Capital Corp Moderna, Inc. Transaction History

Park Place Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $5,143 - $7,727	-74 Reduced 91.36%	7 $0
Q3 2023 Oct 17, 2023	BUY	$96.41 - $126.61 $192 - $253	2 Added 2.53%	81 $8,000
Q2 2023 Aug 04, 2023	BUY	$118.5 - $160.53 $355 - $481	3 Added 3.95%	79 $9,000
Q1 2023 May 02, 2023	BUY	$135.66 - $197.02 $7,189 - $10,442	53 Added 230.43%	76 $11,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2,722 - $4,830	23 New	23 $4,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Park Place Capital Corp with notifications on news.